Literature DB >> 2877823

Relationship between changes in seromucoid concentrations and the rate of oxidation or acetylation of several substrates.

A B Kobusch, S Erill, P du Souich.   

Abstract

This study was carried out to assess the relationship between turpentine-induced elevation of seromucoids and drug metabolism. Six groups of rats were used; one of them received 1 ml of turpentine sc, another received 1 ml of turpentine by gavage (po), and a third group received, ip, 80 mg/kg of phenobarbital daily for 3 days. Three control groups received saline instead of turpentine. Forty-eight hr later, the serum seromucoids were assayed and the rates of N-demethylation of aminopyrine, O-dealkylation of 7-ethoxycoumarin, and hydroxylation of aniline and total cytochrome were determined in liver microsomes. When turpentine was administered sc, seromucoids increased from 3.15 +/- 0.18 to 16.13 +/- 0.84 g/dl (mean +/- SE) (p less than 0.01), but the rates of N-demethylation (p less than 0.01), of O-dealkylation (p less than 0.01) and of hydroxylation (p less than 0.05) were all decreased. In the rats receiving turpentine po, seromucoids remained unchanged, but the rates of N-demethylation and O-dealkylation as well as the concentration of total cytochrome increased (p less than 0.01). Phenobarbital enhanced significantly the rates of N-demethylation, O-dealkylation, and hydroxylation and the total concentration of cytochrome, without modifying the concentration of seromucoids. In another set of experiments we assessed whether turpentine-induced inflammation would affect the in vivo rate of acetylation of sulfamethazine; the results show that inflammation does not affect the rate of acetylation, despite an important increase in seromucoids. It is concluded that, under the present experimental conditions, there is no direct relationship between changes in seromucoids and the rate of drug metabolism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2877823

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  2 in total

1.  Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levels.

Authors:  N Jauregizar; R Calvo; E Suarez; A Quintana; E Raczka; J C Lukas
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

2.  Cytochrome P450 inactivation by serum from humans with a viral infection and serum from rabbits with a turpentine-induced inflammation: the role of cytokines.

Authors:  A M Bleau; M C Levitchi; H Maurice; P du Souich
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.